Response to: 'Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares' by Didierlaurent et al

Ann Rheum Dis. 2021 Dec;80(12):e201. doi: 10.1136/annrheumdis-2019-216670. Epub 2019 Dec 18.

Chio Yokose^{1

2}, Hyon Choi^{3

2

4}

¹ Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA.
³ Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA HCHOI@mgh.harvard.edu.
⁴ Arthritis Research Canada, Richmond, British Columbia, Canada.

No abstract available

Keywords: epidemiology; gout; vaccination.

Publication types